Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Back to school guide: Buses, lunches, key dates
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
0.6587
-0.0068 (-1.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biora Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
August 12, 2024
BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Funding Agreement with Existing Investors
August 12, 2024
$16 million multiple-draw facility to be used as a bridge to anticipated pharma partnership
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
August 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
July 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
July 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
July 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
June 11, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 24, 2024
Via
Benzinga
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
May 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
May 20, 2024
Four clinical device performance studies successfully demonstrate the NaviCap platform’s ability to deliver therapeutics directly to the colon under variable GI conditions and eating schedules
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024
May 15, 2024
BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 15, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
May 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024
May 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
April 30, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 18, 2024
Via
Benzinga
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
April 08, 2024
Claims cover key jet parameters for liquid jet delivery of a drug to the gastrointestinal tract
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
April 04, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 03, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 01, 2024
Via
Benzinga
Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023
March 26, 2024
BIOR stock results show that Biora Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.